Rackspace-Technology-Logo_Black-Aspect-640.png
Onica by Rackspace Technology Achieves the AWS Service Delivery Designation for AWS Glue
November 30, 2022 19:10 ET | Rackspace Technology, Inc.
SAN ANTONIO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT) — a leading end-to-end, multicloud technology solutions company, today announced that Onica by Rackspace...
RAPT Therapeutics_Logo_Color.png
RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress
November 30, 2022 19:05 ET | RAPT Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage, immunology-based biopharmaceutical company focused...
Viracta Logo_Color[30].jpg
Viracta Therapeutics Announces Preliminary Dose-Ranging Data from the Phase 1b/2 Trial of Nana-val in Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors at the ESMO Immuno-Oncology Congress
November 30, 2022 18:10 ET | Viracta Therapeutics, Inc.
SAN DIEGO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact...
Achilles Therapeutics Logo RGB Small.jpg
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022
November 30, 2022 18:05 ET | Achilles Therapeutics PLC
- Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell lung cancer (NSCLC) patients dosed with cNeT monotherapy - - Updated interim Phase I/II results...
Oncocyte_Logo_Horizontal_Main.jpg
Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors
November 30, 2022 18:05 ET | Oncocyte Corporation
IRVINE, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte_Logo_Horizontal_Main.jpg
Oncocyte Announces Executive Leadership Changes
November 30, 2022 18:00 ET | Oncocyte Corporation
IRVINE, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Sarepta- Corporate Logo (Image).jpg
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 30, 2022 18:00 ET | Sarepta Therapeutics, Inc.
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on November 30, 2022...
DIRTT-Logo-Lockup-TM-RGB-Black.png
DIRTT Announces the Closing of Private Placement
November 30, 2022 17:42 ET | DIRTT Environmental Solutions
CALGARY, Alberta, Nov. 30, 2022 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX:DRT, NASDAQ:DRTT), a global leader in industrialized construction, is pleased...
Black-Enochian-Primary-Logo.jpg
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
November 30, 2022 17:20 ET | Enochian BioSciences, Inc.
LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- On November 23, 2022, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC...
CLBT Logo.png
Cellebrite Endpoint Inspector possibilita que empresas façam a coleta remota de aplicativos de trabalho
November 30, 2022 17:19 ET | Cellebrite Inc.
PETAH TIKVA, Israel e TYSONS CORNER, Va., Nov. 30, 2022 (GLOBE NEWSWIRE) -- A Cellebrite DI Ltd. (Nasdaq: CLBT), líder global em soluções de Inteligência Digital (ID) dos setores público e privado,...